Engineered Materials Offer New Framework for Controllable Cellular Immunotherapy
A review in Discover Oncology examines how engineered materials can address manufacturing, delivery, and safety bottlenecks across cellular immunotherapy.
A review in Discover Oncology examines how engineered materials can address manufacturing, delivery, and safety bottlenecks across cellular immunotherapy.
Researchers designed three lipid nanoparticle mRNA vaccines targeting swine influenza hemagglutinin, finding that a swine-to-human antigen induced the broadest cross-reactive ...
A scientific review assesses how nanotechnology-enabled drug delivery systems enhance pharmacokinetics and lung targeting for COVID-19 therapeutics while confronting substantial ...
A scientific review in Discover Biotechnology evaluates next-generation gene-editing, RNA-based, and engineered immune-cell platforms for cancer treatment and immune modulation.
A scientific review in Discover Nano highlights the therapeutic progress and ongoing translational hurdles facing lipid nanoparticle-mediated mRNA delivery systems ...
Researchers and trainees at an international symposium presented emerging RNA mechanisms spanning transcription dynamics, structural regulation, and targeted therapeutic delivery.
Researchers engineered spray-dried mRNA lipid nanoparticle powders that maintain full biological activity after three years of standard refrigeration and enable ...
Nagoya University researchers have developed a non-destructive single-vesicle analysis technique that reads internal microRNAs and surface proteins to pinpoint the ...
A systematic review indicates that while engineered exosomes offer unique biological delivery advantages for cancer therapy, their clinical translation remains ...
A qualitative study in NanoEthics reveals how volatile market conditions and commercialization models during COVID-19 undermined equitable access to life-saving ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine